Citius Oncology (CTOR)

• Market cap: $107M
• 1 day: 4.92%
• 5 days: -5.19%
• 1 month: -28.49%
• 3 months: -26.86%
• 6 months: 40.66%
• Year to date: 7.56%
• 1 year: 31.96%
• 5 years: -87.31%
• 10 years: -87.31%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.